Tonix Pharmaceuticals Holding Corp. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Tonix Pharmaceuticals Holding Corp. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $628K, a 41.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $628K -$453K -41.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $692K -$521K -43% Jun 30, 2024 10-Q 2024-08-16
Q1 2024 $757K -$229K -23.2% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $824K +$109K +15.2% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $1.08M +$241K +28.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.21M +$273K +29% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $986K +$226K +29.7% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $715K -$199K -21.8% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $840K -$228K -21.3% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $940K -$78K -7.66% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $760K -$161K -17.5% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $914K -$344K -27.3% Dec 31, 2021 10-K 2023-03-13
Q3 2021 $1.07M -$128K -10.7% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $1.02M +$577K +131% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $921K +$640K +228% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.26M +$902K +253% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $1.2M +$731K +157% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $441K -$139K -24% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $281K -$298K -51.5% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $356K Dec 31, 2019 10-K 2021-03-15
Q3 2019 $465K Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $580K Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $579K Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.